0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Environmental Sources Human Health Effects Nanoplastics Policy & Risk Sign in to save

In Vivo tracing and systemic organ biodistribution of dermally exposed nano polystyrene

Journal of Hazardous Materials 2025 1 citation ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 53 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Joycie Shanmugiah, Seungyoun Kim, Seungyoun Kim, Hyeju Jeong, Ahreum Hong, Jin Su Kim

Summary

Researchers used radiolabeled nano-sized polystyrene particles to trace how nanoplastics penetrate the skin and distribute throughout the body in a chronic dermal exposure model. They found that the nanoparticles were able to cross the skin barrier and translocate to multiple organs throughout the body. The study suggests that dermal exposure represents a potential route for systemic nanoplastic uptake, challenging assumptions about the skin's ability to fully block these particles.

Polymers
Study Type In vivo

Although the skin barrier assumed to be intact and functionally competent effectively limits the transdermal penetration of exogenous substances, the potential for nanoplastics to penetrate this barrier and translocate systemically remains a critical toxicological concern. In this study, we employed radiolabelled 125I-nano-sized polystyrene (125I-nPS) to trace dermal penetration and to observe systemic biodistribution using a chronic dermal exposure model. Transcriptomic analyses revealed upregulation of inflammation and ageing markers in exposed skin. Transcriptomic analyses revealed upregulation of 294 genes and downregulation of 144 genes, including significant increases in TNF-α, IL-6, CD207, MMP-3, and CCL2 (F.C.>2, P < 0.05). Single Photon Emission Computed Tomography (SPECT) / Computed Tomography (CT) imaging and ex-vivo biodistribution of 125I-nPS revealed significantly enhanced lymphatic uptake. SPECT/CT imaging and ex-vivo biodistribution demonstrated lymph node uptake up to 0.31 ± 0.19 %ID/g (chronic exposure group), accompanied by systemic dissemination to the thymus and lungs. In the prolonged chronic dermal exposure model, nPS progressively translocated from the skin to the lymph nodes, thymus, lungs, liver, and blood over a 4-week period. Our findings provide direct in-vivo evidence that chronic dermal exposure particularly under conditions simulating prolonged environmental insult can facilitate the systemic dissemination of nPS. These results raise critical concerns regarding potential immune modulation, organ-specific toxicity, and skin ageing associated with long-term environmental exposure to nPS.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Comparison of PET tracing and biodistribution between 64Cu-labeled micro-and nano-polystyrene in a murine inhalation model

Using radioactive copper labeling and PET imaging, researchers tracked where inhaled micro- and nano-sized polystyrene particles travel in the body, finding that nanoplastics distributed more widely to organs than microplastics after lung exposure. This is significant for understanding the health risks of airborne plastic particles, which people inhale daily from synthetic textiles, dust, and urban air.

Article Tier 2

The biodistribution of polystyrene nanoparticles administered intravenously in the chicken embryo

Researchers injected polystyrene nanoplastics into chicken embryos and tracked where the particles traveled, finding high accumulations in the heart, liver, and kidneys, with particles crossing critical tissue barriers. This is an important advance in understanding how nanoplastics distribute throughout a developing organism, with potential implications for fetal health.

Article Tier 2

Blood uptake and urine excretion of nano- and micro-plastics after a single exposure.

Mice exposed to polystyrene nanoparticles (100 nm) and microparticles (3 µm) via different routes showed that smaller particles appeared rapidly in blood and were detected in urine, while larger particles cleared more slowly. The study provides direct evidence that nanoplastics can cross biological barriers and enter circulation, with potential for distribution throughout the body.

Article Tier 2

Size-dependent translocation of polystyrene nanoplastics across biological barriers in mammals

This study tracked radiolabeled nanoplastic particles in rats and found that smaller 20-nanometer particles could cross biological barriers that larger 100-nanometer particles could not, including reaching the brain. Both sizes were transferred from mothers to offspring, but through different pathways, revealing that nanoplastic size plays a critical role in determining which organs and tissues are exposed.

Article Tier 2

Orally administered fluorescent nanosized polystyrene particles affect cell viability, hormonal and inflammatory profile, and behavior in treated mice

Researchers found that orally administered fluorescent polystyrene nanoparticles passed through the mouse digestive system and accumulated in multiple organs. The study observed changes in cell viability, hormonal and inflammatory profiles, and behavior in treated mice, providing evidence that ingested nanoplastics can cross biological barriers and affect multiple body systems.

Share this paper